Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYMR | AZN | AMGN | GILD | VRTX |
| Company | Kymera Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 97.77 | 179.81 | 348.31 | 126.63 | 469.67 |
| High | 100.69 | 181.15 | 349.40 | 126.63 | 470.82 |
| Low | 94.62 | 179.28 | 345.49 | 124.44 | 463.76 |
| Latest | 98.25 | 181.02 | 347.01 | 125.05 | 468.42 |
| Change | -1.20 | +4.59 | +2.29 | +0.18 | +1.63 |
| % Change | -1.21% | +2.60% | +0.66% | +0.14% | +0.35% |
| Volume | 1,368,100 | 1,503,825 | 2,304,600 | 8,461,600 | 1,203,800 |
| 20-Day Average Volume | 802,895 | 1,941,235 | 3,095,020 | 9,072,686 | 1,400,380 |
| Previous Close | 99.45 | 176.43 | 344.72 | 124.87 | 466.79 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 82.32 | 180.81 | 342.14 | 128.06 | 445.65 |
| 20-Day Raw Stochastic | 81.00% | 48.89% | 68.34% | 23.15% | 95.28% |
| 20-Day Relative Strength | 67.79 | 47.53 | 52.86 | 42.57 | 60.67 |
| Weighted Alpha | +97.44 | +20.79 | +21.19 | +7.15 | +10.14 |
| Today's Opinion | 72% Buy | 56% Sell | 40% Buy | 72% Sell | 40% Buy |
| Previous Opinion | 72% Buy | 72% Sell | 24% Buy | 72% Sell | 40% Buy |
| Last Month's Opinion | 24% Buy | 8% Buy | 8% Sell | 24% Sell | 40% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.79% since 06/15/26 | +2.12% since 06/15/26 | -1.00% since 06/15/26 | +0.60% since 06/15/26 | +3.99% since 06/15/26 |
| Low | 84.52 on 06/16/26 | 173.65 on 06/18/26 | 334.05 on 06/18/26 | 122.43 on 06/18/26 | 444.21 on 06/16/26 |
| High | 105.00 on 06/22/26 | 181.15 on 06/23/26 | 353.66 on 06/16/26 | 128.20 on 06/17/26 | 470.82 on 06/23/26 |
| 1-Month | |||||
| %Chg | +24.54% since 05/22/26 | -3.21% since 05/22/26 | +2.27% since 05/22/26 | -6.93% since 05/22/26 | +7.80% since 05/22/26 |
| Low | 69.48 on 06/03/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 105.00 on 06/22/26 | 188.72 on 05/27/26 | 358.46 on 06/11/26 | 137.20 on 05/29/26 | 470.82 on 06/23/26 |
| 3-Month | |||||
| %Chg | +27.66% since 03/23/26 | -1.66% since 03/23/26 | -0.79% since 03/23/26 | -8.95% since 03/23/26 | +3.81% since 03/23/26 |
| Low | 69.48 on 06/03/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 105.00 on 06/22/26 | 207.30 on 04/10/26 | 359.45 on 04/09/26 | 142.97 on 04/09/26 | 470.82 on 06/23/26 |
| 6-Month | |||||
| %Chg | +17.62% since 12/23/25 | -1.77% since 12/23/25 | +4.68% since 12/23/25 | -0.11% since 12/23/25 | +2.01% since 12/23/25 |
| Low | 66.21 on 01/20/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 105.00 on 06/22/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 8,180,558 | 273,626,688 | 186,048,144 | 155,034,848 | 118,473,632 |
| Shares Outstanding, K | 82,258 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 39,210,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -311,350,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 34,370,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | -69,230,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 2.02 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.71 on 04/30/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/10/26 | 08/04/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.89 | 15.28 | 14.79 | 26.85 |